Elsevier: Goodman & Snyder: Differential Diagnosis for Physical Therapists Screening for Referral, 5th Edition - Chapter 10 Screening for Urogenital Disease

Chapter 10 Screening for Urogenital Disease

  1. Cannon J: Recognizing chronic renal failure, the sooner, the better. Nursing 2004 34(1):50–53, 2004.
  2. Netter FH: Atlas of human anatomy, ed 5, Philadelphia, 2010, WB Saunders.
  3. Simons DG, Travell JG, Simons LS: Travell & Simons’ myofascial pain and dysfunction: the trigger point manual, ed 2, vol 1, Baltimore, 1999, Williams & Wilkins.
  4. Smith DR, Raney FL, Jr: Radiculitis distress as a mimic of renal pain. J Urol 116:269, 1976.
  5. Eskelinen M: Usefulness of history-taking, physical examination and diagnostic scoring in acute renal colic. Eur Urol 34(6):467–473, 1998. Medline abstracts
  6. Houppermans RP, Brueren MM: Physical diagnosis—pain elicited by percussion in the kidney area. Ned Tijdschr Geneeskd 145(5):208–210, 2001. Medline abstracts
  7. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Available online at http://www.kidney.org/professionals. Accessed January 1, 2011.
  8. Banishing urinary tract infections. Harvard Women’s Health Watch 10(4):4–5, 2002.
  9. Cailliet R: Low back pain syndrome, ed 5, Philadelphia, 1995, FA Davis.
  10. Interstitial Cystitis Association (ICA): About interstitial cystitis. Available online at http://www.ichelp.org/. Accessed Feb. 2, 2011.
  11. Diagnosing and treating interstitial cystitis. Harvard Women’s Health Watch 10(12):3, 2003.
  12. Medical conditions, coping with kidney stones. Harvard Women’s Health Watch 9(4):4–5, 2001.
  13. Gurunadha Rao Tunuguntla HS, Evans CP: Management of prostatitis. Prostate Cancer Prostatic Dis 5(3):172–179, 2002. Medline abstracts
  14. Alexander RB: Treatment of chronic prostatitis. Nat Clin Pract Urol 1(1):2–3, 2004. Available online http://www.medscape.com/viewarticle/494378. Accessed January 3, 2011. Medline abstracts
  15. Krieger JN: NIH consensus definition and classification of prostatitis. JAMA 282(3):236–237, 1999. Medline abstracts
  16. Schaeffer AJ: Classification (Traditional and National Institutes of Health) and demographics of prostatitis. Urology 60:5–7, 2002. Medline abstracts
  17. Pontari MA, Ruggieri MR: Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol 172(3):839–845, 2004. Medline abstracts
  18. Tripp DA, Curtis NJ, Landis JR, et al: Predictors of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome: findings from the National Institutes of Health Chronic Prostatitis Cohort Study. BJU 94(9):1279–1282, 2004.
  19. Schultz PL, Donnell RF: Prostatitis: the cost of disease and therapies to patients and society. Curr Urol Rep 5(4):317–319, 2004. Medline abstracts
  20. Litwin MS, McNaughton-Collins M, Fowler FL: Prostatitis: The National Institutes of Health Chronic Prostatitis Symptoms Index (NIH-CPSI), Smithshire, IL, 2002, The Prostatitis Foundation. Available online at http://www.prostatitis.org/symptomindex.html. Accessed January 03, 2011.
  21. Rex L: Evaluation and treatment of somatovisceral dysfunction of the gastrointestinal system, Edmonds, WA, 2004, URSA Foundation.
  22. Cornel EB, van Haarst EP: Chronic pelvic pain syndrome type 3 successfully treated with biofeedback physical therapy (Abstract). Presented at the American Urological Association 2004 Annual Meeting, May 8–13, 2004, San Francisco, CA. Available online at http://www.prostatitis.org/AmericanUrologicalMeeting04.html. Accessed January 3, 2011.
  23. Zvara P, Folsom JB, Plante MK: Minimally invasive therapies for prostatitis. Curr Urol Rep 5(4):320–326, 2004. Medline abstracts
  24. Sokolov AV: Transrectal microwave hyperthermia in the treatment of chronic prostatitis. Urologiia 5:20–26, 2003. Medline abstracts
  25. Wehbe SA: Minimally invasive therapies for chronic pelvic pain syndrome. Curr Urol Rep 11(4):276–285, 2010. Medline abstracts
  26. Murphy AB: Chronic prostatitis: management strategies. Drugs 69(1):71–84, 2009. Medline abstracts
  27. Kastner C: Update on minimally invasive therapy for chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 9(4): 333–338, 2008. Medline abstracts
  28. Sheeler R: Enlarged prostate. Know when to seek treatment. Available online at http://www.mayoclinic.com/health/prostate-cancer/DS00043. Accessed January 3, 2011.
  29. National Cancer Institute: Prostate cancer. Available online at http://www.nci.nih.gov/cancertopics/types/prostate. Accessed January 03, 2011.
  30. Jemal A: Cancer statistics, 2010. CA Cancer J Clin 60(5):277–300, 2010. Medline abstracts
  31. Carroll PR, Nelson WG: Report to the nation on prostate cancer: introduction. Medscape Hematology-Oncology 7(2), 2004. Available online at http://www.medscape.com/viewarticle/489635. Accessed January 3, 2011.
  32. Logothetis CJ, Lin SH: Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer 5(1):21–28, 2005. Medline abstracts
  33. U.S. Department of Health & Human Services: Diseases and conditions. Accessed January 7, from http://www.hhs.gov/.
  34. Shafik A, Shafik IA: Overactive bladder inhibition in response to pelvic floor muscle exercises. World J Urol 20(6):374–377, 2003. Medline abstracts
  35. Schultz JM: Urinary incontinence. Solving a secret problem. Nursing 2003 (Suppl) 33(11):5–10, 2003.
  36. Bo K, Borgen JS: Prevalence of stress and urge urinary incontinence in elite athletes and controls. Med Sci Sports Exerc 33(11):1797–1802, 2001. Medline abstracts
  37. Hulme J: Regaining bowel and bladder control after cancer, Missoula, MT, 2003, Phoenix Publishers.
  38. D’Amico AV: Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Natl Cancer Inst 95(18):1376–1383, 2003. Medline abstracts
  39. Grise P, Thurman S: Urinary incontinence following treatment of localized prostate cancer. Cancer Control 8(6):532–539, 2002. Available online at http://www.medscape.com/viewarticle/423513. Accessed January 3, 2011.
  40. Wakamatsu MM: Better bladder and bowel control, Boston, 2009, Harvard Medical School.
  41. Yim PS, Peterson AS: Urinary incontinence. Postgrad Med 99(5):137–150, 1996. Medline abstracts
  42. Burrows NR: Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes in the United States and Puerto Rico. MMWR 59(42):1361–1366, 2010. Medline abstracts
  43. Evans N, Forsyth E: End-stage renal disease in people with type 2 diabetes: systemic manifestations and exercise implications. Phys Ther 84(5):454–463, 2004. Medline abstracts
  44. Peterson GM: Selecting nonprescription analgesics. Am J Ther 12(1):67–79, 2005. Medline abstracts
  45. Elseviers MM, De Broe ME: Analgesic abuse in the elderly. Renal sequelae and management. Drugs Aging 12(5):391–400, 1998. Medline abstracts
  46. National Kidney Foundation (NKF): Can analgesics hurt kidneys? Available online at http://www.kidney.org/atoz/atozPrint.cfm?id=23. Accessed January 3, 2011.
  47. Malik J: Understanding the dialysis access steal syndrome: a review of the etiologies, diagnosis, prevention, and treatment strategies. J Vasc Access 9(3):155–166, 2008. Medline abstracts
  48. Holub C, Lamont M: The reliability of the six-minute walk test in patients with end stage renal disease. Acute Care Perspect 11(4):8–11, 2002.
  49. Paton M: Continuous renal replacement therapy. Nursing2003, 33(6):40–50, 2003.
  50. Best treatments for beating bladder cancer. Johns Hopkins Med Lett 15(1):6–7, 2004.
  51. Bladder cancer in women: no time to wait. Harvard Women’s Health Watch 11(7):3–5, 2004.
  52. Jacobs BL: Bladder cancer in 2010: How far have we come? CA Cancer J Clin 60(4):244–272, 2010. Medline abstracts
  53. National Cancer Institute: What you need to know about bladder cancer, Available online at www.cancer.gov/cancertopics/wyntk/bladder. Accessed January 3, 2011.
  54. Ongoing care of patients after primary treatment for their cancer: genitourinary cancers, bladder and kidney. CA Cancer J Clin 53(3):190–191, 2003.
  55. Weiss J: Refractory overactive bladder without hematuria: a presenting symptom of bladder cancer. Presentation at the joint annual meeting of the International Continence Society (ICS) and the International Urogynecological Association (IUA). August 23-27, 2010. Available online at https://www.icsoffice.org/Abstracts/Publish/105/000348.pdf. Accessed December 2, 2010.
  56. National Cancer Institute: What you need to know about kidney cancer, Available online at www.cancer.gov/cancertopics/wyntk/kidneys. Accessed January 3, 2011.
  57. American Cancer Society: Detailed guide: testicular cancer. What are the risk factors for testicular cancer? Available online at http://www.cancer.org. Accessed January 3, 2011.
  58. American Cancer Society: Testicular cancer. Available online at http://www.cancer.org/Cancer/TesticularCancer/DetailedGuide/testicular-cancer-risk-factors. Accessed Feb 2, 2011.
  59. Gajendran VK: Testicular cancer patterns in African-American men. Urology 66(3):602–605, 2005. Medline abstracts
  60. Powe BD: Testicular cancer among African American college men. Am J Mens Health 1(1):73–80, 2007. Medline abstracts
  61. Goodman CC, Fuller K: Pathology: implications for the physical therapist, ed 3, Philadelphia, 2009, WB Saunders.
  62. Lab Values Interpretation Resources: Acute Care Section— APTA Task Force on Lab Values, 2008. Available online at www.acutept.org [members only]. Accessed January 3, 2011.
  63. Irion GL: Lab values update. Acute Care Perspect 13(1):1, 3–5, 2004.
  64. Sherburn M, Guthrie JR, Dudley EC, et al: Is incontinence associated with menopause? Obstet Gynecol 98(4):628–633, 2001. Medline abstracts